The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies.
Maria DąbrowskaJerzy JaroszewiczMarek SitkoJustyna Janocha-LitwinDorota Zarębska-MichalukEwa JanczewskaBeata LorencMagdalena Tudrujek-ZdunekAnna Parfieniuk-KowerdaJakub KlapaczyńskiHanna BerakŁukasz SochaBeata DobrackaDorota DybowskaWłodzimierz MazurŁukasz WażnyRobert FlisiakPublished in: Cancers (2024)
As presented in our study, DAA therapy has proven to be highly effective and safe in patients with active SMTs and HDs. However, therapy discontinuations resulting from liver disease progression remain to be the major concern in HCC patients.